{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:riluzole-oral-suspension",
  "slug": "riluzole-oral-suspension",
  "title": "FDA shortage status: Riluzole Oral Suspension",
  "ingredient": "Riluzole Oral Suspension",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "TEGLUTIK",
    "TIGLUTIK"
  ],
  "therapeutic_categories": [
    "Neurology"
  ],
  "dosage_forms": [
    "Oral Suspension"
  ],
  "routes": [
    "ORAL"
  ],
  "package_count": 4,
  "packages": [
    {
      "package_ndc": "70726-0304-1",
      "product_ndc": "70726-0304",
      "company_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "manufacturer_name": "EDW PHARMA, INC",
      "presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)",
      "availability": "Available",
      "dosage_form": "Oral Suspension",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/26/2024",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70726-0305-1",
      "product_ndc": "70726-0305",
      "company_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "manufacturer_name": "EDW PHARMA",
      "presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)",
      "availability": "Available",
      "dosage_form": "Oral Suspension",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/26/2024",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70726-0306-1",
      "product_ndc": "70726-0306",
      "company_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "manufacturer_name": "EDW PHARMA",
      "presentation": "Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)",
      "availability": "Available",
      "dosage_form": "Oral Suspension",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/26/2024",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70726-0303-1",
      "product_ndc": "70726-0303",
      "company_name": "EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)",
      "manufacturer_name": "EDW PHARMA, INC",
      "presentation": "Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)",
      "availability": "Unavailable",
      "dosage_form": "Oral Suspension",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "01/26/2024",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 3,
    "Unavailable": 1
  },
  "initial_posting_date": "01/26/2024",
  "latest_source_update": "08/17/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}